Literature DB >> 6439213

Glucuronic acid conjugation by hepatic microsomal fractions isolated from streptozotocin-induced diabetic rats.

M H Morrison, G M Hawksworth.   

Abstract

The hepatic glucuronidation of 1-naphthol and 4-nitrophenol (3-methylcholanthrene inducible substrates of glucuronyltransferase, GT 1) was found to be deficient in freshly prepared untreated "native" microsomes from streptozotocin-induced diabetic male rats. The defect was not observed in female rats. Moreover, the glucuronidation of 1-naphthol and 4-nitrophenol was higher in "native" microsomes from male control rats than in those from female controls. This sex difference in the glucuronidation of the GT 1 substrates was abolished by detergent activation of the transferase enzyme in vitro. Streptozotocin treatment did not alter the glucuronidation of paracetamol or phenolphthalein (phenobarbitone inducible substrates for GT 2). This diabetes-induced defect in the glucuronidation of GT 1 substrates was abolished by insulin treatment of the animals and was diminished or completely abolished by detergent activation of the transferase enzyme in vitro. Increased membrane constraint is proposed as the mechanism responsible for the transferase defect. 3-Methylcholanthrene induction abolished the streptozotocin-induced defect in 4-nitrophenol glucuronidation, whereas phenobarbitone did not. This is attributed to the differential effect of these inducers on the microsomal membrane.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439213     DOI: 10.1016/0006-2952(84)90048-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Proceedings of the British Pharmacological Society. Liverpool, 6th-8th April, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

Review 2.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

3.  Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients.

Authors:  Teresa Maria J P Carvalho; Ricardo de Carvalho Cavalli; Sérgio P Cunha; Cláudia O de Baraldi; Maria P Marques; Natalícia J Antunes; Ana Leonor P C Godoy; Vera Lucia Lanchote
Journal:  Eur J Clin Pharmacol       Date:  2010-09-17       Impact factor: 2.953

4.  Diabetes in female rats; changes in liver microsomal aminopyrine N-demethylase and UDP-glucuronyl transferase activities.

Authors:  E Del Villar; P Vega; C Gaule; E Sanchez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

Review 5.  The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.

Authors:  Sang K Kim; Raymond F Novak
Journal:  Pharmacol Ther       Date:  2006-11-13       Impact factor: 12.310

6.  Molecular basis of bilirubin UDP-glucuronosyltransferase induction in spontaneously diabetic rats, acetone-treated rats and starved rats.

Authors:  L Braun; M J Coffey; F Puskás; T Kardon; G Nagy; A A Conley; B Burchell; J Mandl
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

7.  Paracetamol elimination in patients with non-insulin dependent diabetes mellitus.

Authors:  F Kamali; S H Thomas; R E Ferner
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

8.  Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.

Authors:  R J Herman; A Chaudhary; C B Szakacs; D Woo; R Lane; M A Boctor
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.